Neuroimmune Mechanisms in Psychiatric Disorders: Current Evidence on Brain Inflammation, Biomarkers, and Precision Therapeutics
DOI:
https://doi.org/10.64784/260Palabras clave:
Neuroinflammation, Psychiatry, Brain Immunity, Microglia, Astrocytes, Cytokines, Major Depressive Disorder, Schizophrenia, Bipolar Disorder, Anxiety Disorders, Autism Spectrum Disorder, Obsessive-Compulsive Disorder, Biomarkers, Neuroimmunology, Precision Psychiatry.Resumen
The vaginal microbiome has emerged as a fundamental determinant of female reproductive health and a promising therapeutic target for the prevention and management of gynecological and obstetric complications. This review aimed to critically analyze the current scientific evidence regarding emerging microbiome-targeted therapeutic approaches, emphasizing their biological mechanisms, clinical effectiveness, therapeutic potential, and future applications in personalized reproductive medicine. A structured narrative review based on the Scientific Method was conducted using publications retrieved from internationally recognized databases, including PubMed, Scopus, Web of Science, ScienceDirect, SpringerLink, Nature Portfolio, and Google Scholar. Recent evidence demonstrates that vaginal dysbiosis is strongly associated with bacterial vaginosis, recurrent vulvovaginal candidiasis, infertility, recurrent urinary tract infections, preterm birth, and other adverse pregnancy outcomes. The analyzed literature indicates that probiotics currently possess the strongest clinical evidence, while live biotherapeutic products, vaginal microbiota transplantation, postbiotics, prebiotics, and advanced vaginal drug delivery systems represent rapidly evolving therapeutic alternatives with considerable potential for restoring microbial homeostasis. These interventions extend beyond pathogen elimination by promoting immune regulation, epithelial barrier integrity, long-term microbial stability, and personalized therapeutic strategies. Although important methodological limitations remain, including heterogeneity among studies and limited long-term clinical data, microbiome-directed therapies are expected to play an increasingly significant role in precision reproductive medicine. Continued multidisciplinary research and high-quality clinical trials will be essential to facilitate their safe and effective integration into routine gynecological and obstetric practice.
Referencias
• Beurel, E., Toups, M., & Nemeroff, C. B. (2020). The bidirectional relationship of depression and inflammation: Double trouble. Neuron, 107(2), 234–256.
• Chan, K. L., Poller, W. C., Swirski, F. K., & Russo, S. J. (2023). Central regulation of stress-evoked peripheral immune responses. Nature Reviews Neuroscience, 24(10), 591–604. https://doi.org/10.1038/s41583-023-00729-2
• Chaves, C., Dursun, S. M., Tusconi, M., & Hallak, J. E. C. (2024). Neuroinflammation and schizophrenia – Is there a link? Frontiers in Psychiatry, 15, 1356975. https://doi.org/10.3389/fpsyt.2024.1356975
• Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9(1), 46–56.
• Felger, J. C., & Lotrich, F. E. (2013). Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience, 246, 199–229.
• Hartmann, S.-M., Heider, J., Wüst, R., Fallgatter, A. J., & Volkmer, H. (2024). Microglia-neuron interactions in schizophrenia. Frontiers in Cellular Neuroscience, 18, 1345349. https://doi.org/10.3389/fncel.2024.1345349
• Heneka, M. T., Kummer, M. P., & Latz, E. (2014). Innate immune activation in neurodegenerative disease. Nature Reviews Immunology, 14(7), 463–477.
• Herzog, S., et al. (2024). Neuroinflammation, stress-related suicidal ideation, and negative mood in depression. JAMA Psychiatry. Advance online publication. https://doi.org/10.1001/jamapsychiatry.2024.3543
• Khandaker, G. M., Dantzer, R., Jones, P. B., & others. (2017). Immunopsychiatry: Important facts. Psychological Medicine, 47(13), 2229–2237.
• Laricchiuta, D., Papi, M., Decandia, D., et al. (2024). The role of glial cells in mental illness: A systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects. Frontiers in Cellular Neuroscience, 18, 1358450. https://doi.org/10.3389/fncel.2024.1358450
• Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16(1), 22–34.
• Perry, V. H., Holmes, C., & others. (2014). Microglial priming in neurodegenerative disease. Nature Reviews Neurology, 10(4), 217–224.
• Poletti, S., Mazza, M. G., & Benedetti, F. (2024). Inflammatory mediators in major depression and bipolar disorder. Translational Psychiatry, 14, 247.
• Ransohoff, R. M. (2016). How neuroinflammation contributes to neurodegeneration. Science, 353(6301), 777–783.
• Réus, G. Z., Fries, G. R., Stertz, L., et al. (2015). The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience, 300, 141–154.
• Rosenblat, J. D., McIntyre, R. S., & Brietzke, E. (2014). Can anti-inflammatory agents treat symptoms of major depressive disorder? A systematic review and meta-analysis. Journal of Affective Disorders, 168, 1–7.
• Yirmiya, R., Rimmerman, N., & Reshef, R. (2015). Depression as a microglial disease. Trends in Neurosciences, 38(10), 637–658.
• Zeng, Y., Chourpiliadis, C., Hammar, N., et al. (2024). Inflammatory biomarkers and risk of psychiatric disorders. JAMA Psychiatry, 81(11), 1118–1129. https://doi.org/10.1001/jamapsychiatry.2024.2185
• Zhang, Y., et al. (2023). Peripheral cytokine levels across psychiatric disorders: A systematic review and network meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 125, 110740. https://doi.org/10.1016/j.pnpbp.2023.110740
• Zhu, H., Guan, A., Liu, J., Peng, L., Zhang, Z., & Wang, S. (2023). Noteworthy perspectives on microglia in neuropsychiatric disorders. Journal of Neuroinflammation, 20, 223. https://doi.org/10.1186/s12974-023-02901-y
